Literature DB >> 2291878

Hepatic drug clearance: the effect of age using indocyanine green as a model compound.

H A Wynne1, J Goudevenos, M D Rawlins, O F James, P C Adams, K W Woodhouse.   

Abstract

The hepatic extraction ratio and clearance of indocyanine green (ICG) were determined and used to derive apparent liver blood flow in nine subjects between the ages of 22 and 83 years. There was no correlation between the hepatic extraction ratio of ICG and age (rs = -0.435, NS). There was a significant negative correlation between both ICG clearance and age (rs = -0.710, P less than 0.05) and apparent liver blood flow and age (rs = -0.750, P less than 0.05). These results validate the comparison of liver blood flow values derived from ICG clearance in humans over a wide age range and confirm that liver blood flow does fall with age.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2291878      PMCID: PMC1368258          DOI: 10.1111/j.1365-2125.1990.tb03826.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  The use of indocyanine green for the evaluation of hepatic function and blood flow in man.

Authors:  B D WIEGAND; S G KETTERER; E RAPAPORT
Journal:  Am J Dig Dis       Date:  1960-05

3.  The effect of age upon liver volume and apparent liver blood flow in healthy man.

Authors:  H A Wynne; L H Cope; E Mutch; M D Rawlins; K W Woodhouse; O F James
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

4.  Age and the pharmacokinetics of morphine.

Authors:  S P Baillie; D N Bateman; P E Coates; K W Woodhouse
Journal:  Age Ageing       Date:  1989-07       Impact factor: 10.668

5.  THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN.

Authors:  S E Bradley; F J Ingelfinger; G P Bradley; J J Curry
Journal:  J Clin Invest       Date:  1945-11       Impact factor: 14.808

6.  Effect of age on liver function with particular reference to bromsulphalein excretion.

Authors:  E N Thompson; R Williams
Journal:  Gut       Date:  1965-06       Impact factor: 23.059

7.  Plasma level of chlormethiazole and two metabolites after oral administration to young and aged human subjects.

Authors:  R L Nation; J Vine; E J Triggs; B Learoyd
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

8.  The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods.

Authors:  J P Villeneuve; R Huot; D Marleau; P M Huet
Journal:  Am J Gastroenterol       Date:  1982-04       Impact factor: 10.864

9.  Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.

Authors:  A J Wood; R E Vestal; G R Wilkinson; R A Branch; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

10.  Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients.

Authors:  L Storstein; A Larsen; K Midtbø; L Saevareid
Journal:  Acta Med Scand Suppl       Date:  1984
View more
  15 in total

1.  Pharmacokinetic study of omeprazole in elderly healthy volunteers.

Authors:  S Landahl; T Andersson; M Larsson; B Lernfeldt; P Lundborg; C G Regårdh; E Sixt; I Skånberg
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 3.  Drug dosage in the elderly: dermatological drugs.

Authors:  Anna Flammiger; Howard Maibach
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

5.  The pharmacokinetics of zileuton in healthy young and elderly volunteers.

Authors:  R A Braeckman; G R Granneman; C S Locke; J M Machinist; J H Cavannaugh; W M Awni
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

6.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

7.  Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment.

Authors:  Dirk Kropeit; Jürgen Scheuenpflug; Katharina Erb-Zohar; Atef Halabi; Hans-Peter Stobernack; Ellen G J Hulskotte; Arne van Schanke; Holger Zimmermann; Helga Rübsamen-Schaeff
Journal:  Br J Clin Pharmacol       Date:  2017-05-05       Impact factor: 4.335

8.  Relationship between liver function and splenic blood flow (quantitative measurement of splenic blood flow with H2(15)O and a dynamic state method: 2).

Authors:  A Oguro; H Taniguchi; H Koyama; H Tanaka; K Miyata; K Takeuchi; T Inaba; H Nakahashi; T Takahashi
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

Review 9.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

10.  The outcomes of patients with severe hyperbilirubinemia following living donor liver transplantation.

Authors:  Hajime Matsushima; Akihiko Soyama; Mitsuhisa Takatsuki; Masaaki Hidaka; Izumi Muraoka; Tamotsu Kuroki; Susumu Eguchi
Journal:  Dig Dis Sci       Date:  2013-01-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.